MARKET

NVCR

NVCR

Novocure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

63.34
-2.94
-4.44%
After Hours: 62.50 -0.84 -1.33% 18:17 04/03 EDT
OPEN
64.90
PREV CLOSE
66.28
HIGH
65.76
LOW
62.80
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
98.84
52 WEEK LOW
41.51
MARKET CAP
6.31B
P/E (TTM)
-786.8323
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NVCR stock price target is 88.86 with a high estimate of 105.00 and a low estimate of 75.00.

EPS

NVCR News

More
  • Novocure Provides Business Update Related to COVID-19
  • Business Wire · 16h ago
  • Hedge Funds Started Selling NovoCure Limited (NVCR) Before The Coronavirus
  • Insider Monkey · 03/23 05:24
  • German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany
  • Business Wire · 03/20 14:16
  • Why Novocure, Insulet, and Dexcom Are Rising Today
  • MotleyFool.com · 03/19 19:43

Industry

Medical Equipment, Supplies & Distribution
-0.92%
Healthcare Equipment & Supplies
-1.17%

Hot Stocks

Symbol
Price
%Change

About NVCR

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM) and to advance programs testing of TTFields in multiple solid tumor indications through its clinical pipeline. In addition to its clinical and commercial progress in GBM, it is planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and mesothelioma. TTFields are delivered through a portable, medical device. The complete delivery system, which is designed to allow patients to go about their daily activities while receiving continuous cancer treatment, includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories.
More

Webull offers kinds of Novocure Ltd stock information, including NASDAQ:NVCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVCR stock news, and many more online research tools to help you make informed decisions.